Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Senomys(SNMX)- A Taste for Success!!! -- Ignore unavailable to you. Want to Upgrade?

To: DewDiligence_on_SI who wrote (10)	3/27/2005 8:19:15 AM
From: gfp927z	Read Replies (2) \| Respond to of 192

Dew, Some aspects of the Senomyx story which seem appealing include - 1) Extremely quick time to market, avoiding the usual lengthy/expensive/risky FDA hurdles for drug approval. GRAS designtion is all you need. Royalty revenues could start flowing as early as the first half of 2006. 2) The existing collaborations with four of the world's largest food companies indicates significant interest on their part for the technology. 3) Much lower risk compared to the typical bio company. Developing flavor enhancers is a lot easier than finding a cure for cancer for example. 4) Strong IP position. 5) The IPO lockup has passed, so much of the IPO related selling may have already occurred. 6) Good cash position, relatively low burn rate, and revenues could start to flow in 2006. Anyway, the company might have some long term potential, and looks worthy of some serious DD. Frankly, I've become more disillusioned with the bio sector's risks, and find myself gravitating toward the more mundane areas.